Optimization of Pharmacist Medication Management and Mortality in the ICU
Related Experiment Video
Updated: Oct 1, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Susan E Smith1, Kelli R Henry2, Mojdeh S Heavner3
1Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Athens, GA.
Background:
Medication-related morbidity due to inappropriate prescribing, delays in appropriate treatment, and adverse drug events contributes to ICU patient mortality. Comprehensive medication management (CMM) is a care standard provided by pharmacists in collaboration with the interprofessional team. Optimizing ICU pharmacist workload via the pharmacist-to-patient ratio while ensuring daily CMM may reduce mortality.
Research Question:
Is ICU pharmacist staffing, measured by the pharmacist-to-patient ratio and absence of CMM, associated with in-hospital mortality among critically ill adults?
Study Design And Methods:
Adults admitted to an ICU from 64 centers (in the United States, Jordan, and Saudi Arabia) were enrolled in a multicenter observational study that collected patient and team staffing data from August 2023 to January 2025. The primary outcome was in-hospital mortality. The primary exposure was the pharmacist-to-patient ratio calculated per patient, averaged over the ICU stay. A secondary exposure was the absence of CMM for at least 1 day of the ICU stay. Multivariable generalized estimating equations were used to estimate associations with in-hospital mortality, accounting for clustering by center and adjusting for patient-, ICU-, and hospital-level covariates.
Results:
Among 28,795 patients enrolled, the median (interquartile range) pharmacist-to-patient ratio was 1:17 (13-23). Each 1-patient increase in the pharmacist-to-patient ratio was associated with a 1% increase in the odds of in-hospital mortality (OR, 1.01; 95% CI, 1.00-1.01; P = .04). Patients who did not receive pharmacist-delivered CMM for at least 1 day of the ICU stay had 20% higher odds of in-hospital mortality (OR, 1.20; 95% CI, 1.03-1.40; P = .02). Patients cared for at a pharmacist-to-patient ratio of 1:15.1 to 1:46 had 10% higher odds of mortality compared with those cared for at a ratio of 1:7 to 1:15 (OR, 1.10; 95% CI, 1.00-1.22).
Interpretation:
Increasing pharmacist-to-patient ratios and the absence of pharmacist CMM every day were both associated with increased in-hospital mortality.
Related Concept Videos
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Acute Coronary Syndrome IV: Interprofessional Care
Pharmaceutical Poisoning: Potential Scenarios
Drug Dosing: Geriatric Patients
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetic–Pharmacodynamic Relationship: Problems